Copyright Reports & Markets. All rights reserved.

CRISPR and CRISPR-Associated (Cas) Genes-Global Market Status and Trend Report 2016-2026

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of CRISPR and CRISPR-Associated (Cas) Genes

    • 1.1 Definition of CRISPR and CRISPR-Associated (Cas) Genes in This Report
    • 1.2 Commercial Types of CRISPR and CRISPR-Associated (Cas) Genes
      • 1.2.1 Genome Editing
      • 1.2.2 Genetic engineering
      • 1.2.3 gRNA Database/Gene Librar
      • 1.2.4 CRISPR Plasmid
      • 1.2.5 Human Stem Cells
      • 1.2.6 Genetically Modified Organisms/Crops
      • 1.2.7 Cell Line Engineering
    • 1.3 Downstream Application of CRISPR and CRISPR-Associated (Cas) Genes
      • 1.3.1 Biotechnology Companies
      • 1.3.2 Pharmaceutical Companies
      • 1.3.3 Academic Institutes
      • 1.3.4 Research and Development Institutes
    • 1.4 Development History of CRISPR and CRISPR-Associated (Cas) Genes
    • 1.5 Market Status and Trend of CRISPR and CRISPR-Associated (Cas) Genes 2016-2026
      • 1.5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Status and Trend 2016-2026
      • 1.5.2 Regional CRISPR and CRISPR-Associated (Cas) Genes Market Status and Trend 2016-2026

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of CRISPR and CRISPR-Associated (Cas) Genes 2016-2021
    • 2.2 Production Market of CRISPR and CRISPR-Associated (Cas) Genes by Regions
      • 2.2.1 Production Volume of CRISPR and CRISPR-Associated (Cas) Genes by Regions
      • 2.2.2 Production Value of CRISPR and CRISPR-Associated (Cas) Genes by Regions
    • 2.3 Demand Market of CRISPR and CRISPR-Associated (Cas) Genes by Regions
    • 2.4 Production and Demand Status of CRISPR and CRISPR-Associated (Cas) Genes by Regions
      • 2.4.1 Production and Demand Status of CRISPR and CRISPR-Associated (Cas) Genes by Regions 2016-2021
      • 2.4.2 Import and Export Status of CRISPR and CRISPR-Associated (Cas) Genes by Regions 2016-2021

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of CRISPR and CRISPR-Associated (Cas) Genes by Types
    • 3.2 Production Value of CRISPR and CRISPR-Associated (Cas) Genes by Types
    • 3.3 Market Forecast of CRISPR and CRISPR-Associated (Cas) Genes by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of CRISPR and CRISPR-Associated (Cas) Genes by Downstream Industry
    • 4.2 Market Forecast of CRISPR and CRISPR-Associated (Cas) Genes by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of CRISPR and CRISPR-Associated (Cas) Genes

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 CRISPR and CRISPR-Associated (Cas) Genes Downstream Industry Situation and Trend Overview

    Chapter 6 CRISPR and CRISPR-Associated (Cas) Genes Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of CRISPR and CRISPR-Associated (Cas) Genes by Major Manufacturers
    • 6.2 Production Value of CRISPR and CRISPR-Associated (Cas) Genes by Major Manufacturers
    • 6.3 Basic Information of CRISPR and CRISPR-Associated (Cas) Genes by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of CRISPR and CRISPR-Associated (Cas) Genes Major Manufacturer
      • 6.3.2 Employees and Revenue Level of CRISPR and CRISPR-Associated (Cas) Genes Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 CRISPR and CRISPR-Associated (Cas) Genes Major Manufacturers Introduction and Market Data

    • 7.1 Thermo Fisher Scientific
      • 7.1.1 Company profile
      • 7.1.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.1.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
    • 7.2 Editas Medicine
      • 7.2.1 Company profile
      • 7.2.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.2.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Editas Medicine
    • 7.3 Caribou Biosciences
      • 7.3.1 Company profile
      • 7.3.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.3.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Caribou Biosciences
    • 7.4 CRISPR therapeutics
      • 7.4.1 Company profile
      • 7.4.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.4.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of CRISPR therapeutics
    • 7.5 Intellia therapeutics, Inc.
      • 7.5.1 Company profile
      • 7.5.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.5.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Intellia therapeutics, Inc.
    • 7.6 Cellectis
      • 7.6.1 Company profile
      • 7.6.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.6.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Cellectis
    • 7.7 Horizon Discovery Plc
      • 7.7.1 Company profile
      • 7.7.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.7.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Horizon Discovery Plc
    • 7.8 Sigma Aldrich
      • 7.8.1 Company profile
      • 7.8.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.8.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Sigma Aldrich
    • 7.9 Precision Biosciences
      • 7.9.1 Company profile
      • 7.9.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.9.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Precision Biosciences
    • 7.10 Genscript
      • 7.10.1 Company profile
      • 7.10.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.10.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Genscript
    • 7.11 Sangamo Biosciences Inc.
      • 7.11.1 Company profile
      • 7.11.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.11.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Sangamo Biosciences Inc.
    • 7.12 Lonza Group Limited
      • 7.12.1 Company profile
      • 7.12.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.12.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Lonza Group Limited
    • 7.13 Integrated DNA Technologies
      • 7.13.1 Company profile
      • 7.13.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.13.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Integrated DNA Technologies
    • 7.14 New England Biolabs
      • 7.14.1 Company profile
      • 7.14.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.14.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of New England Biolabs
    • 7.15 Origene Technologies
      • 7.15.1 Company profile
      • 7.15.2 Representative CRISPR and CRISPR-Associated (Cas) Genes Product
      • 7.15.3 CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin of Origene Technologies

    Chapter 8 Upstream and Downstream Market Analysis of CRISPR and CRISPR-Associated (Cas) Genes

    • 8.1 Industry Chain of CRISPR and CRISPR-Associated (Cas) Genes
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of CRISPR and CRISPR-Associated (Cas) Genes

    • 9.1 Cost Structure Analysis of CRISPR and CRISPR-Associated (Cas) Genes
    • 9.2 Raw Materials Cost Analysis of CRISPR and CRISPR-Associated (Cas) Genes
    • 9.3 Labor Cost Analysis of CRISPR and CRISPR-Associated (Cas) Genes
    • 9.4 Manufacturing Expenses Analysis of CRISPR and CRISPR-Associated (Cas) Genes

    Chapter 10 Marketing Status Analysis of CRISPR and CRISPR-Associated (Cas) Genes

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      CRISPR and CRISPR-Associated (Cas) Genes-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on CRISPR and CRISPR-Associated (Cas) Genes industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of CRISPR and CRISPR-Associated (Cas) Genes 2016-2021, and development forecast 2022-2026
      Main manufacturers/suppliers of CRISPR and CRISPR-Associated (Cas) Genes worldwide, with company and product introduction, position in the CRISPR and CRISPR-Associated (Cas) Genes market
      Market status and development trend of CRISPR and CRISPR-Associated (Cas) Genes by types and applications
      Cost and profit status of CRISPR and CRISPR-Associated (Cas) Genes, and marketing status
      Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium CRISPR and CRISPR-Associated (Cas) Genes market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the CRISPR and CRISPR-Associated (Cas) Genes industry.

      The report segments the global CRISPR and CRISPR-Associated (Cas) Genes market as:

      Global CRISPR and CRISPR-Associated (Cas) Genes Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global CRISPR and CRISPR-Associated (Cas) Genes Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
      Genome Editing
      Genetic engineering
      gRNA Database/Gene Librar
      CRISPR Plasmid
      Human Stem Cells
      Genetically Modified Organisms/Crops
      Cell Line Engineering

      Global CRISPR and CRISPR-Associated (Cas) Genes Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
      Biotechnology Companies
      Pharmaceutical Companies
      Academic Institutes
      Research and Development Institutes

      Global CRISPR and CRISPR-Associated (Cas) Genes Market: Manufacturers Segment Analysis (Company and Product introduction, CRISPR and CRISPR-Associated (Cas) Genes Sales Volume, Revenue, Price and Gross Margin):
      Thermo Fisher Scientific
      Editas Medicine
      Caribou Biosciences
      CRISPR therapeutics
      Intellia therapeutics, Inc.
      Cellectis
      Horizon Discovery Plc
      Sigma Aldrich
      Precision Biosciences
      Genscript
      Sangamo Biosciences Inc.
      Lonza Group Limited
      Integrated DNA Technologies
      New England Biolabs
      Origene Technologies

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now